○Shinsuke Iida (Department of Hematology and Oncology, Nagoya City University Hospital)
Session information
Medical Seminar
[MeS09] Medical Seminar 9 Treatment options for relapsed and refractory multiple myeloma after lenalidomide-containing therapy
Thu. Feb 17, 2022 12:15 PM - 1:05 PM Room 11 and 12 (Prince Hall 1 and 2, B2F, The Prince Kyoto Takaragaike)
Chair:Shigeki Ito(Hematology and Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine)
Sponsored by Bristol Myers Squibb K.K.